Post-effective Amendment to an S-8 Filing (s-8 Pos)
March 31 2014 - 4:24PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on March 31, 2014
Registration No. 333-169612
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
Under
The Securities Act of 1933
XYRATEX LTD
(Exact name of Registrant as specified in its charter)
Bermuda
|
|
Not Applicable
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification Number)
|
Langstone Road
Havant PO9 1SA
United Kingdom
(011) 44 2392 496000
(Address and telephone number, including area code, of registrants principal executive offices)
XYRATEX LTD
2004 EMPLOYEE STOCK PURCHASE PLAN
(Full title of the plan)
Brad Driver
46831 Lakeview Blvd.
Fremont, CA 94538
(510) 687-5260
(Name, address, and telephone number, including area code, of agent for service)
Copy to
:
Kenneth M. Massaroni
Executive Vice President, General Counsel and
Chief Administrative Officer
Seagate Technology plc
10200 S. De Anza Blvd
P.O. Box 4030
Cupertino, CA 95015
(408) 658-1000
DEREGISTRATION OF SECURITIES
On
September 28, 2010
, the Registrant filed with the Securities and Exchange Commission a registration statement on Form S-8, Registration No. 333-169612 (the Registration Statement), for the sale of common shares, par value U.S.$0.01 per share (the Common Shares), of the Registrant under the Registrants
Xyratex Ltd 2004 Employee Stock Purchase Plan, as amended and restated effective as of May 11, 2010.
On February 26, 2014, the Registrants shareholders approved and adopted, at a special meeting of shareholders, an Agreement and Plan of Merger (the Agreement), dated as of December 21, 2013, by and among the Registrant, Seagate Technology International, an exempted limited liability company incorporated and existing under the laws of the Cayman Islands and an indirect subsidiary of Seagate Technology plc (Parent), and Phoenix Acquisition Limited, an exempted company incorporated and existing under the laws of Bermuda and a wholly-owned Subsidiary of Parent (Merger Sub). Pursuant to the Agreement, upon the issuance of the Certificate of Merger by the Registrar of Companies in Bermuda on March 31, 2014 (the Effective Time), Merger Sub merged with and into the Registrant, and the Registrant continued as the surviving entity of the Merger.
As a result of the Merger, the offering pursuant to the Registration Statement has been terminated. In accordance with an undertaking made by the Registrant in the Registration Statement to remove from registration, by means of a post-effective amendment, any Common Shares registered under the Registration Statement which remain unsold at the termination of the offering, the Registrant hereby removes from registration all Common Shares registered under the Registration Statement that remain unsold as of the Effective Time.
2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing this Post-Effective Amendment No. 1 to Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Form S-8 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cupertino, State of California, on this 31
st
day of March, 2014.
|
XYRATEX LTD
|
|
|
|
|
By:
|
/s/ James Lerner
|
|
|
Name:
|
James Lerner
|
|
|
Title:
|
Chief Executive Officer
|
Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to Form S-8 has been signed below by the following persons in the capacities and on the dates indicated.
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
/s/ James Lerner
|
|
Chief Executive Officer
|
|
March 31, 2014
|
James Lerner
|
|
(Principal Executive Officer)
|
|
|
|
|
|
|
|
/s/ Richard Pearce
|
|
Chief Financial Officer
|
|
March 31, 2014
|
Richard Pearce
|
|
(Principal Financial and Accounting Officer)
|
|
|
|
|
|
|
|
By:
|
/s/ Kenneth M. Massaroni
|
|
Director
|
|
March 31, 2014
|
Kenneth M. Massaroni, duly authorized on behalf of Seagate Technology International
|
|
|
|
|
|
|
|
|
|
|
3
XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Oct 2024 to Nov 2024
XORTX Therapeutics (NASDAQ:XRTX)
Historical Stock Chart
From Nov 2023 to Nov 2024